Duke Street Bio receives FDA Fast Track designation for PARP1-Selective Inhibitor DSB2455 in patients with HRD brain metastases from triple-negative breast cancer
June 16, 2025
June 16, 2025
June 11, 2025
January 8, 2025
January 8, 2025
December 16, 2024
December 9, 2024
December 4, 2024
November 27, 2024
November 19, 2024
October 6, 2025
AmpliCell® Cytokines enable cell expansion optimization, batch-to-batch consistency and easy transition from research to manufacturing TheraPEAK® 293-...
September 30, 2025
New offering to debut at 32nd ESGCT Congress, October 7–10 in Seville, Spain PromoCell GmbH, a leading global manufacturer of primary human cells and ...
September 24, 2025
Takara Bio Europe today announces the launch of Cellartis® MSC EV Wonder™, a defined, xeno-free medium engineered for the scalable production of extra...
Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225